TOPLINE:

Nearly 12% of individuals using preexposure prophylaxis (PrEP) for HIV prevention, were diagnosed with alcohol use disorder (AUD) within 6 months of initiating PrEP, whereas nearly 3% were diagnosed before initiation. Fewer than 9% of those diagnosed received any US Food and Drug Administration (FDA)–approved medication for AUD.

METHODOLOGY:

Researchers carried out a retrospective cohort study using data from the US health claims to assess the prevalence of AUD among individuals using PrEP for the prevention of HIV.

They included 43,913 individuals (mean age, 35.8 years; 90.1% men) who received a PrEP prescription between January 2014 and December 2021.

The study outcome was an AUD diagnosis within 6 months before or after PrEP initiation, identified using suitable codes in i

See Full Page